The organization has applied to the Drugs Controller General of India (DCGI) on October 2, looking for its authorization to direct stage 3 randomized twofold visually impaired fake treatment controlled multicentre preliminary of its COVID-19 antibody applicant. Bharat Biotech, which had looked for DCGI’s gesture for leading stage 3 clinical preliminaries of its COVID-19 antibody […]
